Historical record - last NADAC effective date: 8/17/2016
Product Information
GLIMEPIRIDE 1 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0842 per EA under NDC 42571010005. Its NADAC has been published 129 times since Mar 19, 2014.
FDA first approved this application on Jun 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Micro Labs LimitedNDC
42571010005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/17/2016
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091220FDA Approved
6/29/2012
TE Code
AB
On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 1 MG TABLET has been published 129 times since Mar 19, 2014, and over the history we have for it it has risen 271.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per EA |
|---|---|
| All-time high | $0.0987 (Jan 13, 2016) |
| All-time low | $0.0215 (Jun 18, 2014) |
| Median price | $0.0673 |
| Average price | $0.0572 |
| Largest weekly change | +194.0% (Feb 18, 2015) |
| Weeks tracked | 129 |
| Tracking since | Mar 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+271.4%
Last surveyed Aug 31, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glimepiride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 1 MG TABLET, manufactured by Micro Labs Limited, is $0.0842 per EA (NDC 42571010005), effective Aug 31, 2016.
How has the price of GLIMEPIRIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 1 MG TABLET has risen 271.4%. It has been tracked across 129 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 1 MG TABLET?
Since Mar 19, 2014, the NADAC for GLIMEPIRIDE 1 MG TABLET has ranged from a low of $0.0215 (Jun 18, 2014) to a high of $0.0987 (Jan 13, 2016), with a median of $0.0673 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 1 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 1 MG TABLET, is $0.0222 per EA — about 74% below GLIMEPIRIDE 1 MG TABLET.
Who manufactures GLIMEPIRIDE 1 MG TABLET?
GLIMEPIRIDE 1 MG TABLET (NDC 42571010005) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.